CARBAMAZEPINE METABOLISM IN MAN INDUCTION AND PHARMACOGENETIC ASPECTS

被引:185
作者
EICHELBAUM, M
TOMSON, T
TYBRING, G
BERTILSSON, L
机构
[1] KAROLINSKA INST, HUDDINGE UNIV HOSP, DEPT CLIN PHARMACOL, S-14186 HUDDINGE, SWEDEN
[2] UNIV BONN, DEPT MED, D-5300 BONN, GERMANY
[3] SODER HOSP, DEPT NEUROL, STOCKHOLM, SWEDEN
关键词
D O I
10.2165/00003088-198510010-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The metabolism of carbamazepine (CBZ) was studied in 3 groups of subjects: 6 healthy volunteers given a single dose of 200 mg carbamazepine; 4 epileptic patients on carbamazepine monotherapy; and 5 patients receiving carbamazepine in combination with other anticonvulsants. Carbamazepine kinetics in the patients were investigated by use of 15N-CBZ. The mean plasma clearance of carbamazepine were 19.8, 54.6 and 113.3 ml/h per kg in groups 1, 2, and 3, respectively. The increased clearance in the patients was mainly due to an induction of the epoxide-diol pathway, as reflected by an increased urinary excretion of the trans-CBZ-diol metabolite. The urinary excretion (as a percentage of the administered dose) of 9-hydroxymethyl-10-carboamoylacridan (9-OH-CBZ) was also increased, whereas the excretion of 2-OH-CBZ and 3-OH-CBZ [2-hydroxycarbamazepine and 3-hydroxycarbamazepine] in groups 2 and 3 were decreased in comparison with group 1. 9-OH-CBZ is formed from carbamazepine-10,11-epoxide (CBZ-E) or trans-CBZ-diol, the formation of 9-OH-CBZ was investigated in 3 patients with trigeminal neuralgia treated with carbamazepine or CBZ-E as monotherapy on separate occasions. The urinary excretion of 9-OH-CBZ was 1.9, 3.3 and 4.0% of the trans-CBZ-diol excretion during CBZ-E therapy and 23, 32 and 24%, respectively, during carbamazepine therapy is formed via the epoxide-diol pathway. Data on plasma concentrations of carbamazepine and CBZ-E, and on urinary excretion of trans-CBZ-diol from 4 patients on carbamazepine therapy were used to calculate the plasma clearance of CBZ-E. The hydration of CBZ-E during carbamazepine therapy was found to be induced, but to a lesser extent than the expoxidation and oxidative metabolic reactions of some other drugs was also studied in 8 healthy volunteers. Carbamazepine epoxidation was not correlated to 4-hydroxylation debrisoquine, oxidation of sparteine, 3- and 4-hydroxylation demethylation of antipyrine, demethylation of amitriptyline, or total metabolism of theophylline.
引用
收藏
页码:80 / 90
页数:11
相关论文
共 34 条
  • [1] STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY
    ALEXANDERSON, B
    EVANS, DAP
    SJOQVIST, F
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686): : 764 - +
  • [2] PREDICTION OF STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE FROM SINGLE ORAL DOSE KINETICS - STUDY IN TWINS
    ALEXANDERSON, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) : 44 - 53
  • [3] [Anonymous], 2010, CLIN PHARMACOKINET
  • [4] [Anonymous], 1975, Clinical Pharmacology of Anti-Epileptic Drugs
  • [5] AUTO-INDUCTION OF CARBAMAZEPINE METABOLISM IN CHILDREN EXAMINED BY A STABLE ISOTOPE TECHNIQUE
    BERTILSSON, L
    HOJER, B
    TYBRING, G
    OSTERLOH, J
    RANE, A
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 83 - 88
  • [6] FAMILY STUDY OF ANTIPYRINE CLEARANCE
    BLAIN, PG
    MUCKLOW, JC
    WOOD, P
    ROBERTS, DF
    RAWLINS, MD
    [J]. BRITISH MEDICAL JOURNAL, 1982, 284 (6310) : 150 - 152
  • [8] CHRISTIANSEN J, 1973, ACTA NEUROL SCAND, V49, P543
  • [9] THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM
    DAHLQVIST, R
    BERTILSSON, L
    BIRKETT, DJ
    EICHELBAUM, M
    SAWE, J
    SJOQVIST, F
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) : 815 - 821
  • [10] DAM M, 1980, ANTIEPILEPTIC THERAP, P299